Clinical Trials

The James Cancer Center Columbus, OH

open for enrollment

Pacritinib in Pts w/ Thrombocytopenia & Pri MF, Post-PV MF, or Post- ET MF Prev Tx w/ Ruxolitinib

Protocol: OSU-17278

Full Title

An Open-Label, Randomized, Phase II Dose-Finding Study of Pacritinib in Patients with Thrombocytopenia and Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated with Ruxolitinib

Leukemia Chronic Myeloid Leukemia